GNRH agonist vs GNRH antagonist in infertility treatment.
Phase 3
- Conditions
- Infertility in endometriosis.Endometriosis
- Registration Number
- IRCT20230403057803N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Patients aged between 20 and 40 years
Patients with endometriosis without a history of endometriosis surgery
Patients with anti-mullerian hormone (AMH) level > 1ng/ml
Number of antral follicle count (AFC)>5
Patients with Ca125<200
Absence of untreated endocrine disease
Exclusion Criteria
Patients with uterine structural problems such as polyps or fibroids
Patients with genetic disorders
Patients with a history of poor response to stimulation in previous cycles
History of ovarian hyperstimulation syndrome (OHSS)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oocyte and embryo count and quality. Timepoint: One month after the treatment (it is not possible to compare before and after the treatment within groups. we can only compare the two groups after the treatment.). Method of measurement: Embryologist assessment based on microscopic criteria.
- Secondary Outcome Measures
Name Time Method